Arthritis therapy: A better time, a better day

Rheumatology

Volumn 40, Issue 6, 2001, Pages 603-606

  Roth, S H ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIRHEUMATIC AGENT; BENOXYPROFEN; CARPROFEN; CD4 ANTIGEN; CORTICOSTEROID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2 INHIBITOR; ETANERCEPT; GOLD SALT; INDOMETACIN; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PHENYLBUTAZONE; PIROXICAM; RECOMBINANT DNA; SUDOXICAM; UNCLASSIFIED DRUG; VACCINE;

AGED; ALGORITHM; APHERESIS; ARTHRITIS; CONTROLLED STUDY; DRUG HALF LIFE; DRUG RESEARCH; DRUG SAFETY; DRUG TOXICITY; EDITORIAL; GASTROINTESTINAL HEMORRHAGE; HUMAN; IMMUNOMODULATION; LIVER FAILURE; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS; DRUG THERAPY; HUMANS; NARCOTICS; PAIN;

EID: 0034946402     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (30)

1. Salicylates revisited: Are they still the hallmark of anti-inflammatory therapy?
2. Nonsteroidal antirheumatic drugs
3. A comparison of benoxyprofen and sulindac in patients with rheumatoid arthritis and osteoarthritis
4. Pharmacologic approaches to musculoskeletal disorders
5. Preliminary gastroscopic comparison of carprofen and ibuprofen in patients with rheumatoid arthritis
6. Merits and liabilities of NSAID therapy
7. Piroxicam safety profile
8. Joint destruction after glucocorticoids are withdrawn in early arthritis
9. Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis: Update after a mean of 90 months
10. Inverting the pyramid: Observations and recommendations of new directions in rheumatoid arthritis therapy based on the author's experience
11. Superaspirin: A new kind of drug could make Motrin and Aleve obsolete
12. Cyclooxygenases as the principal targets for the actions of NSAIDs
13. NSAID gastropathy: A new understanding
14. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease
15. Risk and cost of gastrointestinal side effects associated with nonsteroidal anti-inflammatory drugs
16. New advances with COX-2 specific inhibitors: Studies confirm gastro-protective effect
17. Practice guidelines for chronic pain management
18. A consensus statement from the American Academy of Pain Medicine and the American Pain Society: The use of opioids for the treatment of chronic pain
19. Whose pain is it anyhow?
20. The role of opioids in the treatment of osteoarthritis
21. Efficacy and safety of leflunomide compared with placebo and sulfasalazine in active rheumatoid arthritis: A double-blind, randomized, multi-center trial
22. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis
23. Rationale for combination therapy in rheumatoid arthritis. Limitations of randomized clinical trials to recognize possible advantages of combination therapies in rheumatic diseases
24. Do non-immunologically mediated pathways play a role in the pathogenesis of rheumatoid arthritis?
25. A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis
26. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor in rheumatoid arthritis
27. Recombinant human interleukin-1 receptor, type 1 (IL-1R1) in the treatment of patients with active rheumatoid arthritis
28. Treatment of patients with refractory rheumatoid arthritis with extra-corporeal protein A immunoadsorption columns: A pilot study
29. The Prosorba column for treatment of refractory rheumatoid arthritis: A randomized double-blind, sham-controlled trial